Salt-inducible kinase 3 (SIK-3) is also highly expressed in AML patients (Supplemental Fig. S1E) and has been shown to maintain the function of MEF2C by phosphorylating HDAC in AML31,32. This evidence concerns the gene SIK3 and acute myeloid leukemia.